Related by context. All words. (Click for frequent words.) 74 Proxinium TM 74 Advexin 70 OPAXIO 69 Marqibo 69 HuMax EGFr 68 TELCYTA 68 Ceflatonin 68 obatoclax 67 zalutumumab 67 Azedra 67 romidepsin 67 Li Fraumeni Syndrome 67 ixabepilone 67 BAY #-# 67 Clolar ® 66 enzastaurin 66 panitumumab 66 Evoltra 66 ganetespib 66 Amrubicin 66 Genasense 66 pralatrexate 66 sorafenib tablets 66 tanespimycin 66 Amigal 66 Catena ® 65 imatinib mesylate Gleevec 65 thymalfasin 65 Taxotere ® 65 Campath ® 65 Nexavar ® 65 Taxotere R 65 IRX 2 65 Panzem 65 perifosine 65 TREANDA 65 HuMax CD4 65 Vicinium TM 65 Dacogen 65 Treanda 65 Rhucin ® 65 DAVANAT 65 Ceplene 65 Onconase 65 Virulizin ® 65 MGCD# [001] 65 Virulizin R 65 IRESSA 65 FOLOTYN 65 EOquin 64 Oncophage 64 ADVEXIN p# therapy 64 TORISEL 64 UPLYSO 64 TYKERB 64 picoplatin 64 Traficet EN 64 satraplatin 64 Fludara 64 CoFactor 64 HuLuc# 64 axitinib 64 Targretin 64 fidaxomicin 64 vemurafenib 64 Evoltra ® 64 mapatumumab 64 sapacitabine 64 cutaneous T cell 64 Panzem R 64 Reolysin 64 ZOLINZA 64 Civacir 64 Erbitux 64 IMA# 64 Phenoptin 64 Ceflatonin ® 64 MabCampath 64 Dacogen injection 64 Xanafide 64 ponatinib 64 OncoVEX GM CSF 64 Archexin 64 INCB# [001] 64 Avastin bevacizumab 64 YONDELIS 64 lumiliximab 64 Aplidin 64 RSR# 63 TroVax 63 Xcytrin 63 L BLP# 63 TELINTRA 63 Vectibix 63 Fodosine 63 omacetaxine 63 FTY# 63 Insegia 63 Yondelis ® 63 SNT MC# 63 TYZEKA 63 clofarabine 63 EOquin TM 63 ruxolitinib 63 talactoferrin 63 gefitinib Iressa 63 ZYBRESTAT 63 Chemophase 63 BENLYSTA 63 Icatibant 63 MyVax R 63 Carfilzomib 63 TEMODAL 63 Imprime PGG 63 T DM1 63 zanolimumab 63 tamibarotene 63 MOZOBIL 63 Fludara ® 63 Clolar 63 ADVEXIN clinical 63 Alocrest 63 palifosfamide 63 sunitinib malate 63 TheraCIM 63 RG# [001] 63 Velcade bortezomib 63 recurrent refractory 63 #D#C# 63 Gemzar ® 63 YERVOY 63 APOPTONE 63 JAK inhibitor 63 Pixantrone 63 AP# [003] 63 ADVEXIN therapy 63 PEG SN# 63 PXD# 63 rNAPc2 63 cetuximab Erbitux ® 63 AVASTIN 63 CYT# 63 AEG# 63 vorinostat 62 EndoTAG TM -1 62 pediatric acute lymphoblastic 62 oral ridaforolimus 62 eniluracil 62 Actemra 62 Vandetanib 62 sargramostim 62 Orphan Drug 62 teduglutide 62 Allovectin 7 ® 62 INC# 62 Complete Response 62 Restanza 62 tafamidis 62 Fibrillex TM 62 Allovectin 7 62 Cardio Vascu Grow 62 decitabine 62 p# biomarker 62 Zybrestat 62 gastrointestinal stromal tumors GIST 62 Removab 62 relapsed refractory multiple myeloma 62 VIDAZA 62 alvimopan 62 aflibercept 62 Amplimexon 62 TroVax ® 62 lapatinib 62 ALN TTR 62 Sym# 62 IMGN# 62 oral prodrug 62 Ambrisentan 62 FavId 62 KNS # 62 Jevtana 62 telbivudine 62 Nexavar sorafenib 62 Mepact 62 rilonacept 62 BARACLUDE R 62 Azixa 62 Erbitux cetuximab 62 eltrombopag 62 trastuzumab Herceptin 62 Tavocept 62 MEPACT 62 Triolex 62 refractory chronic lymphocytic 62 XYOTAX TM 62 Loramyc R 62 Gleevec Glivec 62 Panzem R NCD 62 docetaxel Taxotere ® 62 Folotyn 62 carfilzomib 62 Arranon 62 refractory Hodgkin lymphoma 62 SUTENT 62 lymphoma CTCL 62 bevacizumab Avastin ® 62 Zarnestra 62 trastuzumab DM1 T DM1 62 DAVANAT R 62 OMAPRO 62 MAGE A3 ASCI 62 Glybera 62 Zingo TM 62 PROCHYMAL 62 sBLA 62 depsipeptide 62 dalbavancin 62 Tarceva TM 62 PLK1 SNALP 62 Rebif ® 62 Pemetrexed 62 pirfenidone 62 Hycamtin 62 Bronchitol 62 BENLYSTA ® 62 lintuzumab 62 alvespimycin 62 Soliris TM eculizumab 62 HspE7 62 COMFORT II 62 SCCHN 62 vidofludimus 62 XL# [003] 62 pertuzumab 62 Campath alemtuzumab 62 glufosfamide 62 Bezielle 61 sorafenib Nexavar 61 Pirfenidone 61 REOLYSIN ® 61 Tamibarotene 61 Raptiva ® 61 forodesine 61 Satraplatin 61 T#I [002] 61 docetaxel Taxotere R 61 nilotinib 61 Mycamine 61 CA4P 61 OvaRex ® MAb 61 BLP# Liposome Vaccine 61 Degarelix 61 neratinib 61 pomalidomide 61 CBLC# 61 docetaxel Taxotere 61 Vidaza 61 Increlex ® 61 XmAb# 61 INCB# [002] 61 amifampridine phosphate 61 custirsen 61 ZACTIMA 61 ELACYT 61 BiovaxID 61 Davanat 61 ofatumumab 61 peginesatide 61 CANCIDAS 61 Cimzia ® 61 Golimumab 61 TNFerade 61 M Vax 61 ThermoDox ® 61 azficel T 61 Phase #/#a trial 61 Aryplase 61 Omacetaxine 61 adecatumumab 61 PREOS 61 HQK 61 HER2 positive metastatic breast 61 Rhucin R 61 malignant ascites 61 cell lymphoma CTCL 61 CR# vcMMAE 61 OncoVEX 61 radiation sensitizer 61 Asentar 61 Glybera R 61 Loramyc ® 61 OXi# 61 acyclovir Lauriad ® 61 HERmark 61 Symadex 61 LEUKINE 61 LymphoStat B 61 PROMACTA 61 EFAPROXYN 61 Excellarate 61 hematologic malignancies 61 infusional 5-FU/LV 61 DexaSite 61 PRT# 61 anti angiogenic agents 61 liposomal doxorubicin 61 Campath 61 Neuradiab 61 R sorafenib tablets 61 Targretin capsules 61 Cellegesic 61 Sandostatin LAR 61 pain palliation 61 Marketing Authorization Application 61 Cotara 61 PrevOnco ™ 61 Viramidine 61 belinostat 61 supplemental biologics 61 afatinib 61 mRCC 61 canakinumab 61 Irinotecan 61 Specifid 61 IMiDs 61 Dalbavancin 61 Aplidin R 61 taliglucerase alfa 61 maribavir 61 Pivotal Phase III 61 PANVAC VF 61 Leukine ® 61 EndoTAGTM 1 61 Alpharadin 61 antibody MAb 61 ONTAK 61 ASA# 61 liposomal formulation 61 ERBITUX 61 ridaforolimus 61 Doxil ® 61 registrational trial 61 gemcitabine chemotherapy 61 CD# antibody [001] 61 nimotuzumab 61 Iluvien ® 61 SEBIVO 61 relapsed SCLC 61 Romiplostim 61 Firazyr 60 phase IIb clinical 60 temsirolimus Torisel ® 60 pancreatic enzyme replacement 60 dasatinib 60 Troxatyl 60 Zolinza 60 AZILECT ® 60 methylnaltrexone 60 OPAXIO TM 60 Pradefovir 60 HuMax CD# 60 Azilect ® 60 mifamurtide 60 Sudhir Agrawal D.Phil 60 AZILECT R 60 PROSTVAC TM 60 lapatinib Tykerb 60 panitumumab Vectibix 60 azacitidine 60 Herceptin trastuzumab 60 Xinlay 60 Nimotuzumab 60 luteinizing hormone releasing 60 SIR Spheres 60 anti angiogenic agent 60 Rhucin 60 CIMZIA TM 60 abiraterone acetate 60 Trastuzumab 60 dacetuzumab 60 StemEx R 60 Genasense ® 60 CCX# 60 mTOR inhibitor 60 Telatinib 60 YONDELIS R 60 NOXAFIL 60 Vidofludimus 60 TRISENOX 60 gastrointestinal stromal tumors 60 crizotinib PF # 60 MGd 60 cetuximab Erbitux R 60 ANTEGREN 60 Cinryze TM 60 Kuvan 60 Zalbin 60 Apoptone 60 fluoropyrimidine 60 Zorbtive TM 60 Orphan Drug status 60 otelixizumab 60 HuMax 60 elacytarabine 60 tesetaxel 60 Guanilib 60 trabectedin 60 Noxafil 60 Clevudine 60 Nanobody 60 Orathecin 60 ONCONASE 60 vismodegib 60 EGFr 60 Onalta 60 IMC A# 60 Cladribine Tablets 60 RhuDex ® 60 Exelixis XL# 60 Cethrin 60 XYOTAX 60 erlotinib Tarceva ® 60 Debio 60 Onrigin 60 Neulasta ® 60 hepatocellular cancer 60 ARIKACE 60 relapsed multiple myeloma 60 SinuNase 60 Leukine 60 CAPHOSOL 60 Vilazodone 60 Aclasta 60 registrational 60 VEGF Trap 60 MEK inhibitors 60 investigational therapies 60 Ixempra 60 systemic ALCL 60 Biologics License Application 60 receptor tyrosine kinase inhibitor 60 CIMZIA ™ 60 Vidaza R 60 cilengitide 60 LBH# 60 pemetrexed Alimta 60 ceftobiprole 60 SUTENT ® 60 bortezomib Velcade 60 ALN VSP 60 histone deacetylase HDAC inhibitor 60 ZEVALIN 60 Boceprevir 60 RAPAFLO 60 fosbretabulin 60 valopicitabine 60 Vidaza azacitidine 60 Glufosfamide 60 PF # [001] 60 L MTP PE 60 chimeric monoclonal antibody 60 Junovan 60 Torisel 60 Plicera 60 Everolimus 60 Defibrotide 60 FOLOTYN ® 60 BRAF inhibitor 60 Combidex 60 Doxil 60 temsirolimus 60 HGS ETR1 60 efalizumab 60 budesonide MMX 60 cutaneous T 60 Exherin TM 60 Plenaxis TM 60 Allovectin 7 R 60 Anticalin R 60 favorable pharmacokinetic profile 60 Epratuzumab 60 bevacizumab Avastin 60 Vectibix monotherapy 60 Polymer Microspheres 60 albinterferon alfa 2b 60 SPRYCEL ® 60 Factor VIIa 60 GSK# [001] 60 tocilizumab 60 paclitaxel Taxol ® 60 ALN PCS 60 vascular disrupting agents 60 metastatic colorectal 60 oral antiviral 60 epigenetic therapies 60 orphan medicinal product 60 IV Busulfex 60 PEGASYS ® 60 Celgene Revlimid 60 Marketing Authorisation Application 60 OHR/AVR# 60 PEG INTRON 60 orBec 60 HGS# 60 pan HDAC inhibitor 60 refractory multiple myeloma 60 Vasovist 60 INTELENCE 60 TKM ApoB 60 G#DT 59 Cimzia TM 59 amrubicin 59 ORENCIA ® 59 NEBIDO 59 Ventavis 59 Mylotarg 59 Rasagiline 59 Nuvion 59 Zirgan 59 Plenaxis R 59 Excellagen 59 castrate resistant prostate cancer 59 ProSavin 59 DC Bead 59 cetuximab Erbitux 59 GATTEX ® 59 bosutinib 59 ZALBIN 59 CEQ# 59 ALN TTR# 59 ADAGIO study 59 TG# [003] 59 Ontak 59 ONCASPAR 59 standard chemotherapy regimen 59 RAV# 59 motexafin gadolinium Injection 59 bortezomib Velcade R 59 ORENCIA R 59 chemotherapy induced neutropenia 59 Xeloda ® 59 thalidomide Thalomid 59 Orphan Drug Designation 59 recurrent NSCLC 59 tivozanib 59 HGS ETR2 59 proteasome inhibitor 59 Fx #A 59 pegfilgrastim 59 ISENTRESS 59 Xcellerated T Cells 59 FUSILEV ® 59 orphan designation 59 BRILINTA 59 imatinib Gleevec 59 Sorafenib 59 surrogate endpoint 59 Xcytrin R 59 investigational immunotherapy 59 Onco TCS 59 BCX# 59 Tarvacin 59 QuadraSphere 59 CD# monoclonal antibody 59 JOULFERON 59 Abiraterone acetate 59 Certican 59 Bendamustine 59 NeoRecormon 59 recurrent squamous cell carcinoma 59 daclizumab 59 Advagraf 59 vandetanib 59 Stimuvax 59 velaglucerase alfa 59 rhThrombin 59 ACZ# 59 Dual Opioid 59 PEG interferon 59 Eribulin 59 R#/MEM # 59 vinorelbine 59 BrachySil TM 59 nitazoxanide 59 PEP# [003] 59 Evoltra R 59 Kepivance 59 Cloretazine R VNP#M 59 Uvidem 59 HoFH 59 EndoTAG 59 Cloretazine 59 Gencaro 59 KRN# 59 ZEVALIN ® 59 anti EGFR antibody 59 ABRAXANE 59 CYT# potent vascular disrupting 59 IL# PE#QQR 59 DOXIL 59 MYCAMINE 59 topotecan 59 #I TM# 59 Abraxane 59 Dasatinib 59 Cimzia ® certolizumab pegol 59 Azedra TM 59 Raptiva R 59 Ilaris 59 rFIXFc 59 oropharyngeal candidiasis 59 BRIM2 59 Revimmune 59 ATL# [001] 59 paclitaxel Taxol R 59 dasatinib Sprycel ® 59 BAL# [002] 59 multiple myeloma MM 59 VPRIV 59 anticancer therapy 59 KRAS mutation 59 Safinamide 59 Cloretazine R 59 HCV protease inhibitor 59 Aptivus ® 59 Tyrima 59 MyVax personalized immunotherapy 59 KALBITOR 59 acyclovir Lauriad R 59 voreloxin 59 Actimmune ® 59 metastatic CRC 59 seliciclib 59 Multikine 59 KIACTA ™ 59 BioNumerik 59 carboplatin paclitaxel 59 OvaRex R 59 Zerenex 59 ISTODAX 59 phase IIa clinical 59 Biologics License Application BLA 59 FDA Approvable Letter 59 Capesaris 59 refractory AML 59 Romidepsin 59 Zenvia Phase III 59 Cetuximab Erbitux 59 Aurexis 59 LAF# 59 tigecycline 59 PDX pralatrexate 59 romiplostim 59 Gleevec imatinib mesylate 59 GATTEX 59 ImClone Erbitux 59 PSMA ADC 59 Generx TM 59 PREOS R 59 ACTEMRA TM 59 ThermoDox R 59 ATryn ® 59 TLR antagonist 59 PrevOnco 59 Gliadel Wafer 59 Arimoclomol 59 anticancer therapies 59 Aviptadil 59 MYDICAR ® 59 PegIntron 59 MabThera Rituxan 59 doxorubicin HCl liposome injection 59 REPLAGAL 59 Orphan Drug Status 59 preclinically 59 NeuroVax TM 59 FRDA 59 Pyridorin 59 HCD# [002] 59 Orphan Drug designations 59 TheraSphere 59 GAMMAGARD 59 FIRMAGON R 59 metastatic hormone refractory 59 ONGLYZA ™ 59 Voraxaze ™ 59 novel VDA molecule 59 metastatic colorectal cancer 59 brivaracetam 59 targeted radiotherapeutic 59 sunitinib 59 investigational drug 59 Evoltra TM 59 mipomersen 59 EndoTAG TM 59 Dendreon Provenge 59 targeting CD# 59 Cancidas 59 Panzem NCD 59 hematological malignancies 59 QAB# 59 Ceplene/IL-2 59 antiangiogenic therapy 59 Sprycel 59 HDAC Inhibitor 59 masitinib 59 elotuzumab 59 proteasome inhibitor bortezomib 59 PKC# 59 Mozobil 59 OncoGel 59 Zenvia ™ 59 PNP inhibitor 59 Taxotere docetaxel 59 pexiganan 59 Prestara TM 59 Nebido 58 Rilonacept 58 Metastatic Colorectal Cancer 58 BARACLUDE ® 58 OncoVex 58 Vitaxin 58 oxaliplatin Eloxatin 58 volociximab 58 ASONEP 58 prucalopride 58 mertansine 58 Cloretazine ® 58 gemcitabine carboplatin 58 CYC# 58 Prestara 58 vosaroxin 58 Dacogen decitabine 58 Gleevec resistant 58 dextromethorphan quinidine 58 Ophena 58 ON #.Na 58 Tarceva erlotinib 58 Paraplatin ® 58 histamine dihydrochloride 58 subcutaneous formulation 58 modified glutathione analog 58 Theratope 58 vinflunine 58 bazedoxifene 58 Copegus ribavirin 58 noninfectious uveitis 58 IND submission 58 EGFR inhibitors 58 Genasense R 58 epothilone 58 Tarvacin TM 58 Xelox 58 viral kinetics 58 CTAP# Capsules 58 PROVENGE 58 Aflibercept 58 dirucotide 58 tyrosine kinase inhibitor 58 Junovan TM 58 Gabapentin GR 58 ongoing Phase 1b 58 Rituxan rituximab 58 MYLOTARG 58 vascular disrupting agent 58 brostallicin 58 Dapagliflozin 58 blinatumomab 58 FOLFIRINOX 58 azacytidine 58 Phase Ib study 58 ALGRX 58 topical diclofenac 58 oral Xeloda 58 omacetaxine mepesuccinate 58 rotigotine transdermal patch 58 LibiGel ® 58 Reverset 58 Solazed 58 Q#IR 58 Genentech Roche 58 tiuxetan 58 Exelon Patch 58 Fabry Disease 58 PDE4 inhibitor 58 solid tumors 58 crofelemer 58 atrasentan 58 Stimuvax R 58 MAb 58 metaglidasen 58 tipranavir 58 metastatic renal cell carcinoma 58 adalimumab Humira 58 ZADAXIN 58 refractory metastatic 58 rituximab Rituxan 58 Loramyc 58 refractory gout 58 atacicept 58 Ceflatonin R 58 pitavastatin 58 Eculizumab 58 regorafenib 58 ofatumumab HuMax CD# 58 Naglazyme 58 Hexvix 58 RIGScan CR 58 BiTE antibody 58 pradefovir 58 APTIVUS 58 GEM OS1 58 Emend 58 ProLindac 58 refractory cutaneous T 58 HYCAMTIN 58 oral FTY# 58 Bevacizumab 58 relapsed ovarian cancer 58 B CLL 58 ABRAXANE ® 58 celgosivir 58 BNC# 58 Orphan Drug designation 58 angiogenesis inhibitor 58 BLA filing 58 bicalutamide 58 Gefitinib 58 entinostat 58 REVLIMID R 58 ROTATEQ 58 ELAPRASE 58 bortezomib Velcade ® 58 Genentech Rituxan 58 Azedra ™ 58 Rescula 58 PEG PAL 58 teriflunomide 58 OMP designation 58 EDEMA3 58 ospemifene 58 Telavancin 58 investigational monoclonal antibody 58 RoACTEMRA 58 Vidaza ® 58 Clofarabine 58 personalized immunotherapy 58 farletuzumab 58 vildagliptin 58 IgG1 monoclonal antibody 58 hormone refractory prostate cancer 58 anticancer compound 58 STELARA TM 58 Perifosine 58 isoform selective 58 Urocidin 58 Alfimeprase 58 Multiferon R 58 castration resistant prostate cancer 58 sipuleucel T 58 PS# [001] 58 MyVax 58 NPM1 58 palliative radiotherapy 58 Oracea TM 58 Enzastaurin 58 Hepatocellular Carcinoma HCC 58 menadione 58 ILUVIEN ® 58 Ocrelizumab 58 DAVANAT ® 58 ataluren 58 MAA submission 58 cediranib 58 PRTX 58 Mipomersen 58 prGCD 58 TRIOLEX 58 tipifarnib 58 Vectibix panitumumab 58 EpCAM 58 PI3K/Akt pathway inhibitor 58 BYDUREON 58 Yondelis 58 virus HCV protease inhibitor 58 predictive biomarkers 58 Telzir 58 sunitinib Sutent ® 58 imatinib Gleevec ® 58 bardoxolone methyl 58 Synvisc One 58 TACI Ig 58 ZYBRESTAT fosbretabulin 58 NV1FGF 58 SinuNase TM 58 DORIBAX 58 Actilon 58 Movectro 58 Chrysalin 58 BYETTA ® 58 systemic fungal infections 58 Pegasys ® 58 febuxostat 58 Caelyx 58 MT# MEDI 58 NEUMUNE 58 CAELYX 58 telaprevir VX 58 ENMD # 58 TBC# 58 cytokine refractory 58 ToGA 58 epratuzumab 58 low dose cytarabine 58 Lilly Gemzar 58 iclaprim 58 ACTEMRA 58 Cloretazine VNP#M 58 Bayer Onyx 58 inhibitor RG# 58 Eloxatin ® 58 Promacta 58 Inhalation Solution 58 Afatinib 58 cancer immunotherapies 58 Pertuzumab 58 Iluvien TM 58 cinacalcet HCl 58 apremilast 58 Talabostat 58 Cimzia certolizumab pegol 58 Bonefos 58 Surfaxin LS 58 HIF PHI 58 Privigen 58 MAXY G# 58 bavituximab 58 Augment Injectable 58 Prochymal 58 factor receptor EGFR 58 NPSP# 58 Ketotransdel 58 lenalidomide Revlimid R 58 indibulin 58 CINTREDEKIN BESUDOTOX 58 icatibant 58 REYATAZ R 58 Trofex 58 Gleevec imatinib 58 AzaSite Plus 58 Æterna Zentaris 58 Cutaneous T 58 Xerecept 58 FOLFOX6 58 K ras mutations 58 ketolide antibiotic 58 Urocidin TM 58 orally administered inhibitor 58 antibody MT# 58 IMC #B 58 mitogen activated ERK kinase 58 oncolytic virus therapies 58 anticancer agent 58 vilazodone 58 Saxagliptin 58 BEXXAR 58 Bortezomib 58 recurrent glioblastoma 58 oncology indications 58 ThermoDox 58 dasatinib Sprycel 58 Diamyd ® 58 Bioral ® 58 MEK inhibitor 58 ISTODAX ® 58 Cytoxan 58 Vion Pharmaceuticals 58 Pazopanib 58 NEUPOGEN 58 Maribavir 58 Acute Radiation Syndrome ARS 58 INTEGRILIN 57 CHMP recommendation 57 Zebinix R 57 Cimzia 57 Quinamed 57 formerly LymphoStat B 57 Eli Lilly Gemzar 57 Soliris eculizumab 57 Afinitor 57 GRN#L 57 AA amyloidosis 57 hematological cancers 57 RDEA# 57 Serdolect ® 57 MGCD# [002] 57 imatinib resistant 57 Tostrex 57 Rexin G